West Announces Fourth-Quarter and Full-Year 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
West Pharma (WST) Tops Q4 EPS by 40c; Guides
February 16, 2023 6:03 AM ESTWest Pharma (NYSE: WST) reported Q4 EPS of $1.77, $0.40 better than the analyst estimate of $1.37. Revenue for the quarter came in at $708.7 million versus the consensus estimate of $657.17 million.
GUIDANCE:
West Pharma sees FY2023 EPS of $7.25-$7.40, versus the consensus of... More
